Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07553234 · ClinicalTrials.gov registry record · NA
Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer Treatment
A NA study, sponsored by University of Chicago.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07553234 is a NA study that has not yet begun recruiting, run by University of Chicago. The registered enrollment target is 20 participants.
The verdict
NCT07553234, a NA study, has not yet begun recruiting, sponsored by University of Chicago.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will be conducted in 2 sequential parts. The first part will be a prospective, observational study. This will be followed by a small interventional, pilot study involving use of fiber supplement (chia seeds). The study aims to evaluate the relationship between the gut microbiome (a diverse ecosystem of microorganisms that affects your health and well-being) and treatment-related gastrointestinal toxicities in patients with HR+/HER2- breast cancer receiving abemaciclib plus endocrine therapy.
Interventions
- OTHER Chia Seeds
- OTHER Stool Sampling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-12-27 |
| Est. Completion | 2030-05-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07553234
The ClinicalTrials.gov registry entry for NCT07553234 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Chia Seeds is the first listed.
NCT07553234 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07553234 about?
NCT07553234 is a clinical study titled "Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer Treatment". This study will be conducted in 2 sequential parts. The first part will be a prospective, observational study. This will be followed by a small interventional, pilot study involving use of fiber supplement (chia seeds). The study aims to evaluate the relationship between the gut microbiome (a divers...
What is the current status of trial NCT07553234?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-12-27. Estimated completion is 2030-05-03.
What interventions are being tested in trial NCT07553234?
The interventions under investigation include: Chia Seeds (OTHER), Stool Sampling (OTHER).
Who is sponsoring clinical trial NCT07553234?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.